杏林製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2015/12/07 | 2,323 | 2,344 | 2,285 | 2,287 | ±0 | ±0% | 191,600 |
2015/12/04 | 2,290 | 2,295 | 2,238 | 2,287 | -51 | -2.2% | 289,100 |
2015/12/03 | 2,334 | 2,345 | 2,316 | 2,338 | -4 | -0.2% | 255,900 |
2015/12/02 | 2,306 | 2,346 | 2,270 | 2,342 | +24 | +1% | 285,300 |
2015/12/01 | 2,329 | 2,341 | 2,307 | 2,318 | -6 | -0.3% | 347,900 |
2015/11/30 | 2,382 | 2,382 | 2,320 | 2,324 | -57 | -2.4% | 375,400 |
2015/11/27 | 2,388 | 2,393 | 2,365 | 2,381 | ±0 | ±0% | 161,200 |
2015/11/26 | 2,390 | 2,420 | 2,379 | 2,381 | +14 | +0.6% | 273,300 |
2015/11/25 | 2,340 | 2,379 | 2,323 | 2,367 | +8 | +0.3% | 264,500 |
2015/11/24 | 2,353 | 2,372 | 2,333 | 2,359 | +18 | +0.8% | 213,600 |
2015/11/20 | 2,307 | 2,348 | 2,294 | 2,341 | +33 | +1.4% | 209,600 |
2015/11/19 | 2,341 | 2,345 | 2,296 | 2,308 | -9 | -0.4% | 265,800 |
2015/11/18 | 2,314 | 2,350 | 2,310 | 2,317 | +8 | +0.3% | 224,500 |
2015/11/17 | 2,280 | 2,316 | 2,265 | 2,309 | +45 | +2% | 298,300 |
2015/11/16 | 2,220 | 2,275 | 2,206 | 2,264 | +6 | +0.3% | 165,800 |
2015/11/13 | 2,230 | 2,258 | 2,211 | 2,258 | +13 | +0.6% | 198,800 |
2015/11/12 | 2,219 | 2,262 | 2,219 | 2,245 | +17 | +0.8% | 235,700 |
2015/11/11 | 2,202 | 2,241 | 2,198 | 2,228 | +31 | +1.4% | 210,500 |
2015/11/10 | 2,187 | 2,197 | 2,171 | 2,197 | -12 | -0.5% | 245,600 |
2015/11/09 | 2,203 | 2,220 | 2,169 | 2,209 | +9 | +0.4% | 349,000 |
2015/11/06 | 2,067 | 2,212 | 2,036 | 2,200 | +152 | +7.4% | 485,700 |
2015/11/05 | 2,031 | 2,057 | 2,020 | 2,048 | +18 | +0.9% | 162,800 |
2015/11/04 | 2,025 | 2,054 | 2,023 | 2,030 | +39 | +2% | 187,000 |
2015/11/02 | 2,022 | 2,025 | 1,980 | 1,991 | -52 | -2.5% | 177,700 |
2015/10/30 | 2,018 | 2,053 | 2,018 | 2,043 | +25 | +1.2% | 160,800 |
2015/10/29 | 2,025 | 2,029 | 1,998 | 2,018 | +6 | +0.3% | 192,500 |
2015/10/28 | 2,025 | 2,033 | 2,000 | 2,012 | +12 | +0.6% | 245,600 |
2015/10/27 | 2,007 | 2,016 | 1,991 | 2,000 | -3 | -0.1% | 224,400 |
2015/10/26 | 1,985 | 2,031 | 1,975 | 2,003 | +50 | +2.6% | 365,400 |
2015/10/23 | 1,960 | 1,968 | 1,941 | 1,953 | +37 | +1.9% | 181,000 |
2015/10/22 | 1,936 | 1,938 | 1,908 | 1,916 | -30 | -1.5% | 142,300 |
2015/10/21 | 1,922 | 1,950 | 1,904 | 1,946 | +16 | +0.8% | 155,500 |
2015/10/20 | 1,936 | 1,936 | 1,902 | 1,930 | +2 | +0.1% | 116,000 |
2015/10/19 | 1,948 | 1,955 | 1,920 | 1,928 | -7 | -0.4% | 95,700 |
2015/10/16 | 1,944 | 1,970 | 1,924 | 1,935 | +11 | +0.6% | 178,000 |
2015/10/15 | 1,872 | 1,927 | 1,872 | 1,924 | +61 | +3.3% | 243,700 |
2015/10/14 | 1,902 | 1,902 | 1,845 | 1,863 | -41 | -2.2% | 201,100 |
2015/10/13 | 1,889 | 1,914 | 1,887 | 1,904 | +23 | +1.2% | 217,000 |
2015/10/09 | 1,865 | 1,895 | 1,840 | 1,881 | +28 | +1.5% | 254,200 |
2015/10/08 | 1,892 | 1,892 | 1,838 | 1,853 | -27 | -1.4% | 272,700 |
2015/10/07 | 1,906 | 1,906 | 1,860 | 1,880 | -26 | -1.4% | 217,600 |
2015/10/06 | 1,901 | 1,920 | 1,882 | 1,906 | +19 | +1% | 252,500 |
2015/10/05 | 1,852 | 1,891 | 1,842 | 1,887 | +67 | +3.7% | 239,200 |
2015/10/02 | 1,841 | 1,842 | 1,802 | 1,820 | -31 | -1.7% | 195,000 |
2015/10/01 | 1,860 | 1,860 | 1,817 | 1,851 | +25 | +1.4% | 170,000 |
2015/09/30 | 1,796 | 1,839 | 1,789 | 1,826 | +38 | +2.1% | 265,600 |
2015/09/29 | 1,851 | 1,851 | 1,782 | 1,788 | -95 | -5% | 304,700 |
2015/09/28 | 1,877 | 1,908 | 1,865 | 1,883 | -16 | -0.8% | 159,300 |
2015/09/25 | 1,870 | 1,911 | 1,865 | 1,899 | +47 | +2.5% | 242,200 |
2015/09/24 | 1,903 | 1,925 | 1,847 | 1,852 | -83 | -4.3% | 347,200 |
2301~
2350
件表示中 / 3695件
類似銘柄と比較する
現在ご覧いただいている「杏林製薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
杏林製薬 | 148,800円 | +8.8% | +99.9% | 3.49% | 9.50倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
ゼリア新薬 | 217,600円 | +3.1% | -6.5% | 2.21% | 10.10倍 | 1.07倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
持田薬 | 309,500円 | +3.0% | +27.5% | 2.58% | 19.59倍 | 0.85倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
栄研化 | 223,000円 | +0.4% | -8.4% | 2.38% | 28.63倍 | 1.60倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
ネクセラファーマ | 87,600円 | +20.3% | - | 0.00% | 154.50倍 | 1.15倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
市場注目の銘柄
チャート関連のコラム